Drugs / Influenza Virus Quadrivalent Inactivated Vaccine
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT03318315 | Feb 2018 → Jul 2019 | avian influenza | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
| Phase 42 trials | ||||||
| Phase 4 | NCT03673345 | Sep 2018 → Dec 2020 | influenza | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
| Phase 4 | NCT03328325 | Dec 2017 → Feb 2020 | influenza | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT05755620 Comparator | Apr 2023 → Oct 2025 | influenza | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Influenza Virus Quadrivalent Inactivated Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03318315 ↗ |
| Known as | IIV4 | “A seasonal quadrivalent inactivated influenza vaccine (IIV4), prepared from influenza viruses propagated in embryonated chicken eggs, protecting against 2 influenza A subtypes...” NCT05755620 ↗2“0.5 mL dose of quadrivalent (IIV-4) vaccine administered once intramuscularly, n=240” NCT03328325 ↗ “one dose of seasonal influenza vaccine (IIV4)” NCT03318315 ↗ |
| Modality | Vaccine | “A seasonal quadrivalent inactivated influenza vaccine (IIV4)” NCT03318315 ↗ |
| Route | Intramuscular | “0.5 ml dose of IIV4 vaccine intramuscularly” NCT03318315 ↗ |